20th Anniversary of “State of Tobacco Control” Shows Policymakers at All Levels of Government Haven’t Fully Embraced Importance of Preventing and Reducing Tobacco Use
Since the American Lung Association first launched its “State of Tobacco Control” report in January 2003, the country has, overall, made tremendous progress in its efforts to prevent and reduce tobacco use. Adult cigarette smoking rates have declined from 21.6% in 2003 to 14% in 2019.8 Youth cigarette smoking rates have fallen even faster among high school students from 22.5% in 2002 to 4.6% in 2020.9
- At the state level, the country has seen significant progress on several tobacco control policies, including: 1) smokefree workplace laws, 2) tobacco taxes and 3) Medicaid coverage of tobacco cessation treatments.
- At the federal level: 1) the U.S. Food and Drug Administration (FDA) gained comprehensive authority over the manufacture, marketing and sales of tobacco products; 2) flavored cigarettes, with the glaring exception of menthol, were prohibited; and 3) the federal age of sale for tobacco products was increased to 21 nationwide.
Tobacco remains the leading cause of preventable death and disease in America, killing 480,000 people each year. In addition, 16 million Americans live with a tobacco-related disease.10
However, in other ways, federal, state and local policy makers have yet to take the steps necessary to eliminate tobacco use or protect another generation of youth from becoming addicted. Significant social, racial, geographic and sexual orientation disparities in who uses tobacco products and who is exposed to secondhand smoke in the U.S. have only become more pronounced as overall tobacco use rates have decreased. While there have been some promising announcements and actions taken by FDA in 2021, unnecessary addiction, disease and death could have been prevented by more assertive federal government action on flavored tobacco products. State progress on comprehensive smokefree workplace laws appears successful over the course of 20 years but has completely stalled since 2012. Tobacco tax increases have slowed in terms of frequency over the past few years, and only one state, Maryland, increased its tobacco taxes in 2021.
The country continues to endure the most significant public health crisis of the last 100 years, COVID-19, and yet it has failed to convince officials that they must sufficiently invest in public health infrastructure and prioritize policies that will protect people during a public health epidemic. The Lung Association’s “State of Tobacco Control” 2022 report continues to offer a road map with solutions for many of these challenges, but the country needs federal, state and local lawmakers to implement them to further drive down smoking and tobacco use rates.
FDA Crawls Forward Towards More Comprehensive Regulation of Tobacco Products; Leaves Products Most Responsible for the Youth E-Cigarette Epidemic on the Market
Facing a court-ordered deadline, in 2021, FDA finally began to implement and enforce pre-market tobacco authorization (PMTA) requirements for e-cigarettes, hookah, pipe tobacco, most cigars and other tobacco products after many years of delay. This progress was due to a court decision in a lawsuit filed by the Lung Association and several public health partners ordering tobacco product manufacturers to submit PMTA applications to FDA by September 9, 2020, and for FDA to review and make decisions on those applications by September 9, 2021.
FDA did issue marketing denial orders for many non-menthol flavored e-cigarettes in 2021. However, when it came to the e-cigarette products with the highest market share and that are the most responsible for the youth vaping epidemic such as JUUL and Vuse, FDA delayed decision on their PMTAs for a significant period of time after the court’s deadline. FDA also issued marketing orders for several high nicotine Vuse tobacco-flavored e-cigarettes and took no action on any PMTA related to menthol e-cigarettes. The Lung Association has repeatedly called for all flavored tobacco products, including e-cigarettes, to be removed from the marketplace. Flavors are a key driver of youth tobacco use, and no evidence has been presented that flavored products can meet the public health standard that the law requires.
A new, potentially large loophole emerged in 2021 in the form of synthetic nicotine, as the FDA’s Center for Tobacco Products asserts its authority only covers nicotine derived from tobacco. E-cigarette companies, including PuffBar, the most used e-cigarette product among teens, appear to be exploiting this legal loophole. Synthetic nicotine flavored e-cigarettes are being used to attempt to evade the Tobacco Control Act. The Lung Association has called for FDA to regulate synthetic nicotine as a drug; if it is to be regulated as a tobacco product, it will require action by Congress.
In Response to Significant Disparities in Tobacco Use in U.S., FDA Makes an Important Announcement on Menthol
Overall, adult cigarette smoking, and tobacco use rates remained level from the previous year in 2019, the latest year of data. As has been the case since “State of Tobacco Control” was first published 20 years ago though, the overall rates mask significant disparities among racial, ethnic, socio-economic and LGBTQ+ communities. Use of commercial tobacco products remains particularly high among Native Americans and Alaskan Natives at 20.9% and lesbian, gay and bisexual adults at 19.2%.11 Adults with lower incomes, lower levels of education and experiencing mental illness or substance abuse also endure significantly higher rates of smoking. While regular, national data is lacking on this topic, studies have shown that smoking and tobacco use can vary significantly amongst sub-populations of Hispanic and Asian Americans as well.
In addition, the declines in cigarette smoking rates observed in recent years has been due almost entirely to non-menthol cigarettes. Menthol cigarettes are used by close to 81% of Black Americansxii and disproportionately by pregnant women, youth and LGBTQ Americans.12 In fact, a study released in 2021 found that menthol cigarettes were responsible for 1.5 million new smokers, 157,000 smoking-related premature deaths and 1.5 million life years lost among African Americans from 1980–2018.13 These disparities in menthol cigarette use are largely the result of targeted marketing by the tobacco industry.
This makes an April 2021 announcement by FDA of its intention to issue proposed rules removing menthol cigarettes and many flavored cigars from the marketplace an important development. However, FDA has said it will take until April 2022 just to propose rules. Then it may take several years to finalize the rule and defend against the inevitable industry lawsuits. This is on top of years of delay from when FDA’s Tobacco Product Scientific Advisory Committee in 2011 and FDA itself in 2013 issued separate reports saying it would be beneficial to public health to remove menthol cigarettes from the market. The American Lung Association applauded this long overdue announcement and urges FDA to act with urgency on this issue in light of the years of delay and the disproportionate burden menthol cigarettes place on many communities experiencing health disparities.